Literature DB >> 23253023

Radiofrequency-assisted liver resection: short-term results in a single institution.

P Ihnat1, P Vavra, L Rudinska, P Ostruszka, J Dostalik.   

Abstract

OBJECTIVES: The main goal of the study was to evaluate the effectiveness and safety of radiofrequency-assisted liver resection.
BACKGROUND: Liver resection is the "gold standard" for patients with resectable liver tumors. In the past years, the role of radiofrequency in liver surgery has been expanded from simple tumor ablation to its use in the technique of radiofrequency-assisted liver resection.
METHODS: Patients with primary or secondary liver tumors, who underwent radiofrequency-assisted liver resection have been included into the prospective study. The acquired data underwent statistical analysis and were compared with the published results of liver resections.
RESULTS: Between January 1, 2007 and September 30, 2009, 53 patients underwent radiofrequency-assisted liver resection. Seventy-six tumours were resected with the mean diameter of 38±19 mm. Mean peroperative blood loss was 170.8±285.4 mL and transfusions were needed postoperatively in 9.4 % cases. The mean hospital stay was 10.6±7.2 days. Postoperative complications were noted in 16.9 % patients; postoperative mortality was 1.9 %.
CONCLUSION: The radiofrequency-assisted liver resection represents a safe and effective way of hepatic parenchyma transaction and to hepatobiliary surgeon it offers a new way of effective transection of liver parenchyma (Tab. 2, Ref. 23).

Entities:  

Mesh:

Year:  2013        PMID: 23253023     DOI: 10.4149/bll_2013_005

Source DB:  PubMed          Journal:  Bratisl Lek Listy        ISSN: 0006-9248            Impact factor:   1.278


  2 in total

1.  Advancement in liver laparoscopic resection - development of a new surgical device.

Authors:  P Vavra; L Karnik; M Skrobankova; J Jurcikova; P Ihnat; P Zonca; M Peteja; A El-Gendi; S Czudek
Journal:  Braz J Med Biol Res       Date:  2018-03-01       Impact factor: 2.590

2.  Technical development of a new semispherical radiofrequency bipolar device (RONJA): ex vivo and in vivo studies.

Authors:  Petr Vavra; Marek Penhaker; Jan Grepl; Jana Jurcikova; Jiri Palecek; Michal Crha; Jana Nowakova; Martin Hasal; Martina Skrobankova; Petr Ostruszka; Peter Ihnat; Patricie Delongova; Dana Salounova; Nagy A Habib; Pavel Zonca
Journal:  Biomed Res Int       Date:  2014-04-09       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.